398 related articles for article (PubMed ID: 29155217)
21. Neutrophil elastase-dependent cleavage compromises the tumor suppressor role of EMILIN1.
Pivetta E; Danussi C; Wassermann B; Modica TM; Del Bel Belluz L; Canzonieri V; Colombatti A; Spessotto P
Matrix Biol; 2014 Feb; 34():22-32. PubMed ID: 24513040
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.
Houghton AM; Rzymkiewicz DM; Ji H; Gregory AD; Egea EE; Metz HE; Stolz DB; Land SR; Marconcini LA; Kliment CR; Jenkins KM; Beaulieu KA; Mouded M; Frank SJ; Wong KK; Shapiro SD
Nat Med; 2010 Feb; 16(2):219-23. PubMed ID: 20081861
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines.
Clancy DM; Henry CM; Sullivan GP; Martin SJ
FEBS J; 2017 Jun; 284(11):1712-1725. PubMed ID: 28374518
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response.
Mittendorf EA; Alatrash G; Qiao N; Wu Y; Sukhumalchandra P; St John LS; Philips AV; Xiao H; Zhang M; Ruisaard K; Clise-Dwyer K; Lu S; Molldrem JJ
Cancer Res; 2012 Jul; 72(13):3153-62. PubMed ID: 22564522
[TBL] [Abstract][Full Text] [Related]
25. Streptococcus pneumoniae disrupts pulmonary immune defence via elastase release following pneumolysin-dependent neutrophil lysis.
Domon H; Oda M; Maekawa T; Nagai K; Takeda W; Terao Y
Sci Rep; 2016 Nov; 6():38013. PubMed ID: 27892542
[TBL] [Abstract][Full Text] [Related]
26. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances.
Houghton AM
Cell Cycle; 2010 May; 9(9):1732-7. PubMed ID: 20404546
[TBL] [Abstract][Full Text] [Related]
27. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives.
Ibáñez-Vea M; Zuazo M; Gato M; Arasanz H; Fernández-Hinojal G; Escors D; Kochan G
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):113-123. PubMed ID: 29032490
[TBL] [Abstract][Full Text] [Related]
28. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
[TBL] [Abstract][Full Text] [Related]
29. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy.
Yin Z; Li C; Wang J; Xue L
Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569
[TBL] [Abstract][Full Text] [Related]
30. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil Heterogeneity in Cancer: From Biology to Therapies.
Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC
Front Immunol; 2019; 10():2155. PubMed ID: 31616408
[TBL] [Abstract][Full Text] [Related]
32. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
[TBL] [Abstract][Full Text] [Related]
33. Neutrophils support lung colonization of metastasis-initiating breast cancer cells.
Wculek SK; Malanchi I
Nature; 2015 Dec; 528(7582):413-7. PubMed ID: 26649828
[TBL] [Abstract][Full Text] [Related]
34. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
35. Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.
Drews-Elger K; Iorns E; Dias A; Miller P; Ward TM; Dean S; Clarke J; Campion-Flora A; Rodrigues DN; Reis-Filho JS; Rae JM; Thomas D; Berry D; El-Ashry D; Lippman ME
Breast Cancer Res Treat; 2014 Nov; 148(1):41-59. PubMed ID: 25270120
[TBL] [Abstract][Full Text] [Related]
36. Human colon carcinoma cells synthesize and secrete alpha 1-proteinase inhibitor.
Keppler D; Markert M; Carnal B; Berdoz J; Bamat J; Sordat B
Biol Chem Hoppe Seyler; 1996 May; 377(5):301-11. PubMed ID: 8828821
[TBL] [Abstract][Full Text] [Related]
37. Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis.
Sevmis M; Yoyen-Ermis D; Aydin C; Bilgic E; Korkusuz P; Uner A; Hamaloglu E; Esendagli G; Karakoc D
Immunol Invest; 2017 Oct; 46(7):663-676. PubMed ID: 28872973
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.
Yoshida M; Taguchi A; Kawana K; Ogishima J; Adachi K; Kawata A; Nakamura H; Sato M; Fujimoto A; Inoue T; Tomio K; Mori M; Nagamatsu T; Arimoto T; Koga K; Hiraike OW; Oda K; Kiyono T; Osuga Y; Fujii T
Int J Oncol; 2018 Oct; 53(4):1580-1590. PubMed ID: 30066851
[TBL] [Abstract][Full Text] [Related]
39. Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role?
Gonzalez-Aparicio M; Alfaro C
J Immunol Res; 2019; 2019():6252138. PubMed ID: 31093511
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of equine neutrophil elastase release and superoxide anion generation following secretagogue activation: a potential mechanism for antiproteinase inactivation.
Dagleish MP; Pemberton AD; Brazil TJ; McAleese SM; Miller HR; Scudamore CL
Vet Immunol Immunopathol; 1999 Dec; 72(3-4):257-75. PubMed ID: 10628671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
